The activation of the AIM2 inflammasome triggered the release of pro-inflammatory cytokines, such as interleukin (IL)-1α and tumor growth factor (TGF)-β in exacerbated PBMCs from COPD patients in a caspase-4 noncanonical inflammasome-dependent manner [39]. Here, AIM2 is linked to chronic obstructive pulmonary disease.